Biologics manufacturers cite complex research and development process,along with FDA scrutiny, as reason for costly - but worthy - drugs
Brittany Scurto, PA-C: How to Discuss an Integrative Medicine Approach With Patients
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Atopic Dermatitis Identified as Possible Risk Factor for Headache Disorders, Migraine
ReV Up Your Vitiligo Treatment Strategies
Guselkumab Demonstrates Significant Improvement in Psoriasis Symptoms and HRQoL, Reduces Sexual Impairment and Stigmatization
Nivolumab Plus Talazoparib Does Not Induce Responses in Heavily Pretreated Melanoma